Cel Sci Corporation (CVM)

[Fosco1]

Pres is out,

See slide 20 which matches on the lower boundaries of stage III+IVa survival as I have published in SA article :

https://docs.google.com/spreadsheets/d/1iVkDqatmv_R9kQgKPYy-dLizhwAlaq-LQbD5T1venV4/edit#gid=611558201

(I didn't consider those figures because I wanted a conservative analysis but it is even better if they do indeed reflect the study population)

Btw the old sheet link is still valid but is available on google request, because I think it holds obsolete assumptions to be widespread, I prefer the new sheet

What to say then : This kind of survival curve must imply an even better OSI of Multikine group or a high dropout rate, but even the higher dropouts rates imply efficacy, drop outs would have to be well above 20% to imply so much delay in 298th occurrence

Fosco